GlassScriptPhysician profile
Gurpreet S Dhillon
NPI 1831399229
$5,341.85
in general payments reported to CMS, 2019-2025
19 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.88 · 2020: $790 · 2021: $154 · 2022: $523 · 2023: $732 · 2024: $2,607 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,492 · Education: $317 · Travel and Lodging: $48.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,491.86 |
| Education | $316.92 |
| Travel and Lodging | $48.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,889.32 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $790.00 | 2020 | |
| Kerecis Limited | $316.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mimedx Group, INC. | $242.42 | 2024-2025 | |
| Triad Life Sciences INC. | $233.33 | 2022 | |
| Smith+Nephew, INC. | $201.05 | 2021-2024 | Renasys Touch |
| Convatec INC. | $149.59 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $134.65 | 2024-2025 | Nuzyra |
| Cardiovascular Systems INC. | $127.22 | 2021 | |
| Ascensia Diabetes Care US INC. | $43.58 | 2025 | |
| Boston Scientific Corporation | $30.21 | 2024 | Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $29.89 | 2024 | Arcalyst |
| Medline Industries LP | $27.83 | 2022 | |
| Genzyme Corporation | $27.74 | 2024 | |
| Kci USA, INC. | $22.36 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $22.13 | 2023 | Zetuvit Plus |
| Reprise Biomedical, INC. | $18.32 | 2024 | Miro3d |
| Allergan, INC. | $17.88 | 2019 | |
| Next Science LLC | $17.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurpreet Dhillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.